Predictors of response to rTMS for major depression
Part of Mental health clinical trials.
This study looks at brain and heart-related measurements to predict who is most likely to improve with rTMS (repetitive transcranial magnetic stimulation) for depression. It may help future patients by identifying markers of treatment response.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 18 and 65 years old and can give informed consent
- You have diagnosed major depression (MDD) and your depression is currently moderate to severe
- You’ve tried antidepressant medications and didn’t get enough relief, or you couldn’t tolerate them
- You’re an outpatient and can follow the full treatment schedule
- You have not started or changed psychiatric medications in the past 4 weeks
- You can pass required safety checks for rTMS and MRI (brain scan)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using brain-related “biomarkers” from your scans to guide rTMS can improve depression that hasn’t responded to at least one antidepressant. It may help by targeting brain circuits linked to depression more precisely.
This study tests a non-invasive brain stimulation treatment (repetitive transcranial magnetic stimulation, or rTMS) in people with major depression who did not respond to antidepressant medicines. It may help some participants improve depression symptoms over time.
This study compares two types of repetitive transcranial magnetic stimulation (rTMS) to treat depression. One type uses a brain scan (fMRI) to guide the treatment, while the other uses a standard approach. It may help people whose depression hasn't improved with medication.
This study tests whether ongoing rTMS treatments can help people who already improved after an initial round of rTMS for depression. It aims to keep the benefits going and prevent relapse.
This study tests how a specific kind of brain stimulation (repetitive transcranial magnetic stimulation) works for people with depression that has not responded to standard treatments. If you qualify, it may help doctors understand the mechanism and improve options for treatment-resistant depression.
This study looks at how the brain's frontal lobe (DLPFC) works during memory tasks in people with treatment-resistant depression. It compares brain activity between depressed patients and healthy controls using MRI and possibly a brain stimulation technique (rTMS). It aims to understand why some people don't respond to standard treatments.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.